Key statistics
As of last trade Lyell Immunopharma Inc (LYEL:NSQ) traded at 1.20, 9.63% above its 52-week low of 1.09, set on Sep 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.22 |
---|---|
High | 1.23 |
Low | 1.18 |
Bid | 1.19 |
Offer | 1.20 |
Previous close | 1.22 |
Average volume | 567.23k |
---|---|
Shares outstanding | 256.00m |
Free float | 208.42m |
P/E (TTM) | -- |
Market cap | 312.32m USD |
EPS (TTM) | -0.8297 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 17:10 BST.
More ▼
Announcements
- Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
- Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day
- Lyell Immunopharma Announces Participation in September Investor Conferences
- Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024
- Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology
- Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
- Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
- Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting
- Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
- Lyell Immunopharma Announces Participation in March Investor Conferences
More ▼